Mutations in RUNX1T1 (encoding cyclin-D-related protein, a transcriptional regulator) and WDR17 (WD repeat-containing protein 17) were identified in 3 patient samples in the cohort and predicted to be likely cancer driver mutations impacting protein function by all 4 algorithms (Fig 3A). This evidence concerns the gene RUNX1T1 and cancer.